Skip to main content
. Author manuscript; available in PMC: 2020 Apr 2.
Published in final edited form as: Food Funct. 2019 Apr 2;10(4):2138–2147. doi: 10.1039/c9fo00333a

Table 2.

Concentrations of TMAO, relevant serum measures and dietary intakes in each diet arm before and after intervention. Data shown is mean and SD at each time pointa.

Measurea Healthy Eating Diet
Mediterranean Diet
Baseline, n=57 6 Months, n=45 Baseline, n=58 6 Months, n=45
Serum Concentrations or Concentration Ratios
TMAO, µM 3.3 (2.0) 3.8 (2.5) 4.4 (5.8) 3.8 (2.5)
Betaine, µM 10.2 (3.9) 11.3 (4.6) 11.6 (4.0) 11.5 (4.0)
Choline, µM 12.8 (4.0) 13.1 (4.1) 14.2 (4.8) 13.7 (3.7)
Carnitine, µM 31.3 (14.3) 32.4 (14.9) 36.7 (14.6) 37.0 (15.9)
γ-Butyrobetaine, µM 0.9 (0.4) 0.9 (0.4) 1.1 (0.5) 1.0 (0.4)
TMAO:Betaine 0.35 (0.25) 0.34 (0.20) 0.43 (0.83) 0.34 (0.19)
TMAO:Choline 0.26 (0.14) 0.28 (0.15) 0.31 (0.40) 0.28 (0.18)
TMAO:Carnitine 0.12 (0.07) 0.12 (0.06) 0.13 (0.19) 0.11 (0.06)
TMAO:γ-Butyrobetaine 4.47 (2.79) 4.24 (2.28) 4.82 (9.06) 4.12 (2.22)
a

Data shown is mean and SD at each time point. None of the measures were significantly changed by dietary intervention as determined from mixed models ANOVA using diet group and time as factors and adjustment for baseline age and smoking status. TMAO concentration and its ratios with precursor molecules were natural log transformed before analysis; the other variables did not require transformation.